These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3078080)

  • 1. 5-HT receptor subtype-specific drugs and the cardiovascular system.
    van Heuven-Nolsen D
    Trends Pharmacol Sci; 1988 Dec; 9(12):423-5. PubMed ID: 3078080
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular remodeling and the peripheral serotonergic system.
    Ayme-Dietrich E; Aubertin-Kirch G; Maroteaux L; Monassier L
    Arch Cardiovasc Dis; 2017 Jan; 110(1):51-59. PubMed ID: 28017279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of noradrenaline release in human cardiovascular tissues.
    Göthert M
    Pharmacol Toxicol; 2003 Apr; 92(4):156-9. PubMed ID: 12753416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotonin and its receptors in the cardiovascular system].
    Nadeev AD; Zharkikh IL; Avdonin PV; Goncharov NV
    Eksp Klin Farmakol; 2014; 77(5):32-7. PubMed ID: 25033570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cardiovascular effects of serotonin receptor agonists and antagonists (I)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(5):441-7. PubMed ID: 8291931
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cardiovascular effects of serotonin receptor agonists and antagonists (II)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(6):553-61. PubMed ID: 8135597
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.
    Cambridge D; Whiting MV; Butterfield LJ; Marston C
    Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system.
    Nagatomo T; Rashid M; Abul Muntasir H; Komiyama T
    Pharmacol Ther; 2004 Oct; 104(1):59-81. PubMed ID: 15500909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and regional haemodynamic responses to microinjection of 5-HT agonists in the rostral ventrolateral medulla in the rat.
    Lovick TA
    Neurosci Lett; 1989 Dec; 107(1-3):157-61. PubMed ID: 2533333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
    Hiley CR; Hoi PM
    Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases.
    Imamdin A; van der Vorst EPC
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin (5HT) and its antagonists: involvement in the cardiovascular system.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1984; 11(5):439-55. PubMed ID: 6098391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
    McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
    Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord serotonin receptors in cardiovascular regulation and potentiation of the pressor response to intrathecal substance P after serotonin depletion.
    Hasséssian H; Poulat P; Hamel E; Reader TA; Couture R
    Can J Physiol Pharmacol; 1993 Jul; 71(7):453-64. PubMed ID: 7694781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
    Villalón CM; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands for the investigation of 5-HT autoreceptor function.
    Roberts C; Price GW; Middlemiss DN
    Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.
    Ramage AG
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S120-31. PubMed ID: 16465176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor.
    Maura G; Roccatagliata E; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):323-6. PubMed ID: 3821924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.